Skip to main content

Select Drug Profiles

Multiple Myeloma, Oncology

Targeting CD38, Isatuximab Produces Impressive Responses in Relapsed or Refractory Multiple Myeloma

Gene-Expression Signature Validated as Prognostic Marker in Stage II Colon Cancer

Melanoma, Oncology

Combination Immunotherapy Makes Progress in Advanced Melanoma

A New Paradigm Matching Targeted Therapy to Molecular Alterations Independent of Tumor Type

Prostate Cancer

Is the Glass Half Empty or Half Full? First Study Compares Robotic-Assisted Surgery and Open Radical Prostatectomy

Lung Cancer, Oncology

Nivolumab plus Ipilimumab Combination Promotes Durable Responses in Advanced Lung Cancer

Prostate Cancer

Shorter Hypofractionated Therapy New Standard for Prostate Cancer

Lung Cancer, Oncology

Alectinib Potential First-Line Treatment for NSCLC Associated with ALK Mutation

Conference Correspondent

Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety

Page 107 of 244
Results 1061 - 1070 of 2438